These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24079384)

  • 1. An investigation of the effects of antiretroviral central nervous system penetration effectiveness on procedural learning in HIV+ drug users.
    Wilson MJ; Martin-Engel L; Vassileva J; Gonzalez R; Martin EM
    J Clin Exp Neuropsychol; 2013; 35(9):915-25. PubMed ID: 24079384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score.
    Arentoft A; Troxell K; Alvarez K; Aghvinian M; Rivera Mindt M; Cherner M; Van Dyk K; Razani J; Roxas M; Gavilanes M
    Viruses; 2022 May; 14(6):. PubMed ID: 35746623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficits in complex motor functions, despite no evidence of procedural learning deficits, among HIV+ individuals with history of substance dependence.
    Gonzalez R; Jacobus J; Amatya AK; Quartana PJ; Vassileva J; Martin EM
    Neuropsychology; 2008 Nov; 22(6):776-86. PubMed ID: 18999351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance.
    Marra CM; Zhao Y; Clifford DB; Letendre S; Evans S; Henry K; Ellis RJ; Rodriguez B; Coombs RW; Schifitto G; McArthur JC; Robertson K;
    AIDS; 2009 Jul; 23(11):1359-66. PubMed ID: 19424052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease.
    Garvey L; Winston A; Walsh J; Post F; Porter K; Gazzard B; Fisher M; Leen C; Pillay D; Hill T; Johnson M; Gilson R; Anderson J; Easterbrook P; Bansi L; Orkin C; Ainsworth J; Palfreeman A; Gompels M; Phillips AN; Sabin CA;
    Neurology; 2011 Feb; 76(8):693-700. PubMed ID: 21339496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence.
    Gonzalez R; Schuster RM; Vassileva J; Martin EM
    J Clin Exp Neuropsychol; 2011 Aug; 33(7):735-52. PubMed ID: 21480022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort.
    Smurzynski M; Wu K; Letendre S; Robertson K; Bosch RJ; Clifford DB; Evans S; Collier AC; Taylor M; Ellis R
    AIDS; 2011 Jan; 25(3):357-65. PubMed ID: 21124201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.
    Ances BM; Roc AC; Korczykowski M; Wolf RL; Kolson DL
    J Neurovirol; 2008 Oct; 14(5):418-24. PubMed ID: 19040188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verbal and spatial working memory among drug-using HIV-infected men and women.
    Martin E; Keutmann MK; Fogel JS; Maki PM; Gonzalez R; Vassileva J; Rubin LH; Hardy D
    J Neurovirol; 2018 Aug; 24(4):488-497. PubMed ID: 29687402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of procedural learning on Iowa Gambling Task performance among HIV+ individuals with history of substance dependence.
    Gonzalez R; Wardle M; Jacobus J; Vassileva J; Martin-Thormeyer EM
    Arch Clin Neuropsychol; 2010 Feb; 25(1):28-38. PubMed ID: 19939850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.
    Carvalhal A; Gill MJ; Letendre SL; Rachlis A; Bekele T; Raboud J; Burchell A; Rourke SB;
    J Neurovirol; 2016 Jun; 22(3):349-57. PubMed ID: 26572786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
    Letendre S; Marquie-Beck J; Capparelli E; Best B; Clifford D; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Morgello S; Simpson D; Grant I; Ellis RJ;
    Arch Neurol; 2008 Jan; 65(1):65-70. PubMed ID: 18195140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.
    Tozzi V; Balestra P; Salvatori MF; Vlassi C; Liuzzi G; Giancola ML; Giulianelli M; Narciso P; Antinori A
    J Acquir Immune Defic Syndr; 2009 Sep; 52(1):56-63. PubMed ID: 19731418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral neuropenetration scores better correlate with cognitive performance of HIV-infected patients after accounting for drug susceptibility.
    Fabbiani M; Grima P; Milanini B; Mondi A; Baldonero E; Ciccarelli N; Cauda R; Silveri MC; De Luca A; Di Giambenedetto S
    Antivir Ther; 2015; 20(4):441-7. PubMed ID: 25516553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV, antiretroviral therapies, and the brain.
    Liner KJ; Ro MJ; Robertson KR
    Curr HIV/AIDS Rep; 2010 May; 7(2):85-91. PubMed ID: 20425562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders.
    Sharma I
    HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated neurocognitive disorders: antiretroviral regimen, central nervous system penetration effectiveness, and cognitive outcomes.
    Cross HM; Combrinck MI; Joska JA
    S Afr Med J; 2013 Sep; 103(10):758-62. PubMed ID: 24079630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals.
    Baker LM; Paul RH; Heaps-Woodruff JM; Chang JY; Ortega M; Margolin Z; Usher C; Basco B; Cooley S; Ances BM
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):487-92. PubMed ID: 25900078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double dissociation of HIV and substance use disorder effects on neurocognitive tasks dependent on striatal integrity.
    Martin EM; Gonzalez R; Vassileva J; Bechara A
    AIDS; 2019 Oct; 33(12):1863-1870. PubMed ID: 31259761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.